Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

IDT Expanding Vaccine Capacity

September 21, 2010 8:53 am | News | Comments

IDT Biologika GmbH, a global integrated contract manufacturer of vaccines and biopharmaceuticals, introduced plans to expand its viral vaccine production capacity with the addition of a new high-speed filling line and additional lyophilisation capacity.


FDA Panel Backs VIVITROL For Opioid Addiction

September 21, 2010 8:50 am | News | Comments

Alkermes, Inc. announced that the U.S. Food and Drug Administration Psychopharmacologic Drugs Advisory Committee voted 12 to 1 that VIVITROL should be approved for the treatment of opioid dependence.


Structural Molecule Worsens Pneumonia

September 21, 2010 8:42 am | News | Comments

A structural molecule and the cellular pump that regulates its levels influence the severity of pneumonia and could provide new ways of treating the lung infection, which is a leading cause of hospitalization and death.


Marijauna-Like Chemical Controls Pain from Injury

September 21, 2010 8:40 am | News | Comments

American and Italian researchers have found that a novel drug allows anandamide – a marijuana-like chemical in the body – to effectively control pain at the site of an injury.


New Pathway Regulates Immune Balance

September 21, 2010 8:27 am | News | Comments

St. Jude Children's Research Hospital scientists have identified a new pathway that helps control the immune balance through reciprocal regulation of specialized T lymphocytes, which play very different inflammatory roles.


Preclinical Data Shows MultiStem Benefits

September 21, 2010 7:56 am | News | Comments

Athersys, Inc. announced the publication of a key study demonstrating that intravenous injection of MultiStem, Athersys' multipotent adult progenitor stem cell therapy product, provides neurovascular protection after traumatic brain injury.


PTC Recieves Orphan Drug Grant from FDA

September 21, 2010 7:45 am | News | Comments

PTC Therapeutics, Inc. announced a grant award of approximately $1.6 million from the FDA Office of Orphan Products Development to support an ongoing Phase 3 study of ataluren in patients with nonsense mutation cystic fibrosis.


Advanced Clinical Improves Trials With Codified Delivery

September 21, 2010 7:27 am | News | Comments

Advanced Clinical, a leading provider of clinical research services, is accelerating clinical trials through codified delivery methodologies, tools and techniques.


Almac Facility Passes First Inspection

September 21, 2010 7:02 am | News | Comments

Almac’s Clinical Technologies division announced that it had successfully passed one of the UK’s first joint routine GCP/GMP Medicines and Healthcare Products Regulatory Agency inspections at its Craigavon, UK site.


Mylan Producing Generic Prograf

September 21, 2010 6:47 am | News | Comments

The drugmaker Mylan Inc. said it received Food and Drug Administration approval for a generic version of the Astellas Pharma drug Prograf, which is used to prevent rejection of transplanted organs.


Three Lasker Awards Given Out

September 21, 2010 6:46 am | by Malcolm Ritter | News | Comments

Three scientists have won prestigious medical prizes - one for devising a treatment for a major cause of vision loss and two for laying the groundwork for an explosion in obesity research.


Brain Tangles Offer Alzheimer's Clue

September 21, 2010 6:43 am | by Lauran Neergaard | News | Comments

That sticky gunk coating Alzheimer's patients' brains gets all the notoriety, but another culprit is gaining renewed attention: Protein tangles that clog brain cells and just might determine how fast patients go downhill.


FDA Extends Avastin Review Til December

September 21, 2010 6:40 am | News | Comments

Drugmaker Roche said that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.


FDA Gives Go-Ahead to New Medtronic Stent

September 21, 2010 5:55 am | News | Comments

Medtronic Inc., the world's largest medical device maker, said it has received U.S. approval for a new artery-bracing stent that may be easier for surgeons to implant.


Sanofi Diabetes Drug Effective

September 21, 2010 5:50 am | News | Comments

Sanofi-Aventis said that a study of its experimental diabetes drug showed better blood sugar control than placebo. The study included 361 patients with type 2 diabetes who randomly received either lixisenatide, the company's diabetes injectable, or a sham treatment.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.